@article{eef3414ba5524384b4c94088652a128e,
title = "Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO)",
abstract = "The protection provided by natural versus hybrid immunity from COVID-19 is unclear. We reflect on the challenges from trying to conduct a randomized post-SARS-CoV-2 infection vaccination trial study with rapidly evolving scientific data, vaccination guidelines, varying international policies, difficulties with vaccine availability, vaccine hesitancy, and a constantly evolving virus.",
author = "Eleftherios Mylonakis and Joseph Lutaakome and Jain, {Mamta K.} and Rogers, {Angela J.} and Jos{\'e} Molt{\'o} and Susana Benet and Ahmad Mourad and Files, {D. Clark} and Henry Mugerwa and Cissy Kityo and Francis Kiweewa and Nalubega, {Mary Grace} and Jonathan Kitonsa and Evelyn Nabenkema and Murray, {Daniel D.} and Dominique Braun and Dena Kamel and Higgs, {Elizabeth S.} and Hatlen, {Timothy J.} and Kan, {Virginia L.} and Adriana Sanchez and John Tierney and Eileen Denner and Deborah Wentworth and Babiker, {Abdel G.} and Davey, {Victoria J.} and Gelijns, {Annetine C.} and Matthews, {Gail V.} and Thompson, {B. Taylor} and Lane, {H. Clifford} and Neaton, {James D.} and Lundgren, {Jens D.}",
note = "Funding Information: Supported by the US Operation Warp Speed program; the National Institute of Allergy and Infectious Diseases and Leidos Biomedical Research for the INSIGHT Network; the National Heart, Lung, and Blood Institute; the Research Triangle Institute for the Prevention and Early Treatment of Acute Lung Injury (PETAL) Network; the Cardiothoracic Surgical Trials Network (CTSN); the US Department of Veterans Affairs; and grants from the governments of Denmark (number 126 from the National Research Foundation), Australia (from the National Health and Medical Research Council), the UK (MRC_UU_12023/23 from the Medical Research Council), and Singapore (COVID19RF-005 from the National Medical Research Council). The research was, in part, funded by National Institutes of Health (NIH) Agreement 1OT2HL156812-01 and NCI contract 75N91019D00024, task order number 020F00039. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the NIH. D.L.B is on the advisory boards of Gilead, MerckSharpe & Dohme, Pfizer, and ViiV, and receives travel grants from ViiV Healthcare. G.M. receives research grants from Gilead, AbbvieInc. ViiV Healthcare, and Janssen, and is on the advisory boards of Gileadand AstraZeneca. The other authors declare no competing interests. Funding Information: D.L.B is on the advisory boards of Gilead, MerckSharpe & Dohme, Pfizer, and ViiV, and receives travel grants from ViiV Healthcare. G.M. receives research grants from Gilead, AbbvieInc., ViiV Healthcare, and Janssen, and is on the advisory boards of Gileadand AstraZeneca. The other authors declare no competing interests. Funding Information: Supported by the US Operation Warp Speed program ; the National Institute of Allergy and Infectious Diseases and Leidos Biomedical Research for the INSIGHT Network; the National Heart, Lung, and Blood Institute ; the Research Triangle Institute for the Prevention and Early Treatment of Acute Lung Injury (PETAL) Network ; the Cardiothoracic Surgical Trials Network (CTSN); the US Department of Veterans Affairs ; and grants from the governments of Denmark (number 126 from the National Research Foundation ), Australia (from the National Health and Medical Research Council ), the UK (MRC_UU_12023/23 from the Medical Research Council ), and Singapore (COVID19RF-005 from the National Medical Research Council ). The research was, in part, funded by National Institutes of Health (NIH) Agreement 1OT2HL156812-01 and NCI contract 75N91019D00024, task order number 020F00039. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the NIH. Publisher Copyright: {\textcopyright} 2022 Elsevier Inc.",
year = "2022",
month = aug,
day = "12",
doi = "10.1016/j.medj.2022.07.003",
language = "English (US)",
volume = "3",
pages = "531--537",
journal = "Med",
issn = "2666-6359",
publisher = "Cell Press",
number = "8",
}